Xencor (XNCR) Cash from Operations (2013 - 2026)
Xencor (XNCR) posted quarterly Cash from Operations of 67628000.0 for Q1 2026, down 316.94% year-over-year from 31173302.26 in Q1 2025, and down 30.78% quarter-over-quarter from 51711000.0 in Q4 2025.
Powered by 
Analysis
Xencor (XNCR) Cash from Operations (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Cash from Operations for 14 consecutive years, with 67628000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 316.94% year-over-year to 67628000.0; the TTM figure through Mar 2026 stood at 186525000.0 (down 15.46% YoY), while the FY2025 annual figure was 135117000.0, up 33.17% from the prior year.
- Cash from Operations eased to 67628000.0 in Q1 2026 per XNCR's latest filing, from 51711000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 44269000.0 in Q2 2022 and bottomed at 67628000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 26963176.47 across 5 years, with a median of 30614000.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Operations jumped 558.56% — and 2023, when it plunged 2235.7%.
- Xencor's Cash from Operations stood at 24431000.0 in 2022, then soared by 174.37% to 18169000.0 in 2023, then plunged by 374.3% to 49837000.0 in 2024, then decreased by 3.76% to 51711000.0 in 2025, then slumped by 30.78% to 67628000.0 in 2026.
- Business Quant data shows XNCR's Cash from Operations at 67628000.0 in Q1 2026, 51711000.0 in Q4 2025, and 30817000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | -55.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.66 Mn |
| Mar 31, 2026 | -67.63 Mn |
| Dec 31, 2025 | -51.71 Mn |
| Sep 30, 2025 | -30.82 Mn |
| Jun 30, 2025 | -36.37 Mn |
| Mar 31, 2025 | -16.22 Mn |
| Dec 31, 2024 | -49.84 Mn |
| Sep 30, 2024 | -28.14 Mn |
| Jun 30, 2024 | -67.35 Mn |
| Mar 31, 2024 | -56.86 Mn |
| Dec 31, 2023 | 18.17 Mn |
| Sep 30, 2023 | -27.28 Mn |
| Jun 30, 2023 | -38.20 Mn |
| Mar 31, 2023 | -30.61 Mn |
| Dec 31, 2022 | -24.43 Mn |
| Sep 30, 2022 | -1.17 Mn |
| Jun 30, 2022 | 44.27 Mn |
| Mar 31, 2022 | 5.82 Mn |
| Dec 31, 2021 | 61.79 Mn |
| Sep 30, 2021 | -39.02 Mn |